Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis.

Clinical rheumatology - 1 May 2010

Tesija-Kuna Andrea, Grazio Simeon, Miler Marijana, Vukasovic Ines, Peric Porin, Vrkic Nada

Abstract excerpt

Antibodies against mutated citrullinated vimentin (anti-MCV) are of a comparable diagnostic value in rheumatoid arthritis (RA) as antibodies targeting citrullinated peptides (anti-CCP). Anti-CCP are present in up to 15% of psoriatic arthritis (PsA) patients, while the prevalence of anti-MCV in PsA patients has been poorly investigated. The aim of the present study was to assess the prevalence and relevance of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies
Share to Arthritis, Psoriatic
Share to Autoantibodies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Citrulline

Share to Enzyme-Linked Immunosorbent Assay

Share to Peptides

Share to Prevalence

Share to Vimentin

Source

Identifiers

PMID: 20069329
DOI: 10.1007/s10067-009-1345-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis.PMID 20069329Read ↗

Higher levels of autoantibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis than in patients with psoriasis vulgaris.Semantic proximity Read ↗

Diagnostic value of antibodies against mutated citrullinated vimentin for rheumatoid arthritis.Semantic proximity Read ↗

Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy.Semantic proximity Read ↗

Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis.Semantic proximity Read ↗

Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis.Semantic proximity Read ↗

Antibodies to citrullinated vimentin are a specific and sensitive marker for the diagnosis of rheumatoid arthritis.Semantic proximity Read ↗

Antibodies to mutated citrullinated vimentin and anti-cyclic citrullinated peptide antibodies in inflammatory bowel disease and related arthritis.Semantic proximity Read ↗

Mutated citrullinated vimentin antibodies in rheumatoid arthritis.Semantic proximity Read ↗

Anti-mutated citrullinated vimentin antibody and rheumatoid factor (prevalence and association) in rheumatoid arthritis patients; Saudi and non-Saudi.Semantic proximity Read ↗

Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis.Semantic proximity Read ↗

Are anti-CCP antibodies in psoriatic arthritis patients a biomarker of erosive disease?Semantic proximity Read ↗

The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.